21st Apr 2021 14:44
OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Chief Executive Officer Stephen O'Hara buys 47,857 shares at 53.0 pence, and Rene Kamminga, CEO of OptiBiotix Ltd, buys 35,000 shares at 52.4p, together worth GBP43,704, on Tuesday. O'Hara now has 10.2 million shares, a 11.6% stake, while the purchase is Kamminga's only holding.
Current stock price: 52.40 pence
Year-to-date change: down 9.7%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
OptiBiotix Health